Xu Lin, Lu Yuanjun, Wang Ning, Feng Yibin
School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 999077, China.
Antioxidants (Basel). 2022 May 8;11(5):922. doi: 10.3390/antiox11050922.
Non-alcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease without effective therapy. Selenium, as an essential trace element for humans, is notable for its antioxidant properties. The previous study shows that selenium levels in NAFLD patients are lower than normal ones. Selenium supplementation can effectively alleviate metabolic disorders by relieving anti-oxidative stress and anti-inflammatory regulation. However, the correlation between selenium and NAFLD has not been fully clarified. Herein, we review the current studies on selenium in regulating the different stages of NAFLD and summarize relevant clinical trials to highlight the potential roles of selenium in NAFLD treatment.
非酒精性脂肪性肝病(NAFLD)是最常见的慢性肝病,尚无有效治疗方法。硒作为人体必需的微量元素,以其抗氧化特性而闻名。先前的研究表明,NAFLD患者的硒水平低于正常水平。补充硒可以通过减轻抗氧化应激和抗炎调节来有效缓解代谢紊乱。然而,硒与NAFLD之间的相关性尚未完全阐明。在此,我们综述了目前关于硒在调节NAFLD不同阶段的研究,并总结了相关临床试验,以突出硒在NAFLD治疗中的潜在作用。